Schedule 13D ownership disclosure
Madrigal Pharmaceuticals Inc
Security class unavailable · CUSIP: 558868105
Event date: 2023-11-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,987,702
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-120429
- Form type
- SC 13D
- Filer
- BAKER BROS. ADVISORS LP
- CIK
- CIK 1263508
- Filed
- Nov 21, 2023
- Reporting period
- Nov 17, 2023
- Description
- Schedule 13D beneficial ownership